Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
52.91
+0.91 (1.75%)
At close: Dec 20, 2024, 4:00 PM
52.66
-0.25 (-0.47%)
After-hours: Dec 20, 2024, 6:26 PM EST
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.02 billion as of December 20, 2024. Its market cap has increased by 256.87% in one year.
Market Cap
2.02B
Enterprise Value
1.78B
1-Year Change
256.87%
Ranking
Category
Stock Price
$52.91
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.02B, an increase of 556.38%. That is a compound annual growth rate of 56.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.02B | 201.71% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omnicell | 2.06B |
| Agios Pharmaceuticals | 2.04B |
| TransMedics Group | 2.03B |
| PACS Group | 2.03B |
| Wave Life Sciences | 2.01B |
| Akero Therapeutics | 1.98B |
| Supernus Pharmaceuticals | 1.98B |
| Mirum Pharmaceuticals | 1.97B |